Bank of America’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$824 Buy
180
+8
+5% +$37 ﹤0.01% 6529
2025
Q1
$839 Buy
172
+2
+1% +$10 ﹤0.01% 6397
2024
Q4
$1.14K Hold
170
﹤0.01% 6341
2024
Q3
$1.32K Sell
170
-10,369
-98% -$80.3K ﹤0.01% 6263
2024
Q2
$63.2K Buy
10,539
+7,214
+217% +$43.3K ﹤0.01% 5598
2024
Q1
$30K Sell
3,325
-5,599
-63% -$50.4K ﹤0.01% 5789
2023
Q4
$84.5K Buy
8,924
+2,482
+39% +$23.5K ﹤0.01% 5515
2023
Q3
$76.7K Buy
6,442
+1,362
+27% +$16.2K ﹤0.01% 5477
2023
Q2
$124K Sell
5,080
-26,695
-84% -$654K ﹤0.01% 5267
2023
Q1
$995K Sell
31,775
-2,758
-8% -$86.3K ﹤0.01% 4188
2022
Q4
$2.43M Buy
34,533
+11,350
+49% +$799K ﹤0.01% 3518
2022
Q3
$2M Buy
23,183
+21,935
+1,758% +$1.89M ﹤0.01% 3655
2022
Q2
$103K Sell
1,248
-3,847
-76% -$318K ﹤0.01% 5668
2022
Q1
$847K Sell
5,095
-9,721
-66% -$1.62M ﹤0.01% 4731
2021
Q4
$2.48M Buy
14,816
+9,204
+164% +$1.54M ﹤0.01% 3727
2021
Q3
$484K Buy
5,612
+3,365
+150% +$290K ﹤0.01% 4877
2021
Q2
$122K Sell
2,247
-978
-30% -$53.1K ﹤0.01% 5626
2021
Q1
$192K Buy
3,225
+1,609
+100% +$95.8K ﹤0.01% 5415
2020
Q4
$84K Sell
1,616
-273
-14% -$14.2K ﹤0.01% 5337
2020
Q3
$92K Sell
1,889
-779
-29% -$37.9K ﹤0.01% 5121
2020
Q2
$138K Buy
2,668
+857
+47% +$44.3K ﹤0.01% 4943
2020
Q1
$79K Sell
1,811
-1,175
-39% -$51.3K ﹤0.01% 5061
2019
Q4
$120K Buy
2,986
+618
+26% +$24.8K ﹤0.01% 5107
2019
Q3
$78K Buy
2,368
+791
+50% +$26.1K ﹤0.01% 5336
2019
Q2
$122K Buy
1,577
+354
+29% +$27.4K ﹤0.01% 5145
2019
Q1
$217K Buy
1,223
+933
+322% +$166K ﹤0.01% 4769
2018
Q4
$67K Buy
290
+186
+179% +$43K ﹤0.01% 5348
2018
Q3
$23K Buy
+104
New +$23K ﹤0.01% 5729